moray

About Moray Wright

Moray is CEO of Parkwalk, which he co-founded in 2009.

26 March 2018

Cambridge Touch Technologies – UCEF V and Opportunities Fund investment

By |March 26th, 2018|

We have recently closed an investment in Cambridge Touch Technologies for the University of Cambridge Enterprise Fund V and the Parkwalk Opportunities Fund.

CTT spun-out of the Centre for Advanced Photonics and Engineering (CAPE) at the University of Cambridge. The technology has been developed in collaboration with the laboratory of Professor Arokia Nathan with whom the […]

MediaGamma – Parkwalk closes Investment

By |March 15th, 2018|

We are delighted to announce that Parkwalk and the UCL Technology Fund have co-led a £2m funding of MediaGamma, a UCL Business spin-out developing  predictive analytics software.

The company has developed a world leading enterprise-grade reinforcement machine learning (self-learning) platform, delivering decisions in under five milliseconds. It has proven its technology in programmatic advertising, building and training […]

Brainomix – Parkwalk closes follow-on investment

By |March 7th, 2018|

We have recently closed an investment in Brainomix for the Parkwalk Opportunities EIS Fund and the University of Oxford Innovation Fund IV.

Brainomix, the medical imaging company using artificial intelligence (AI) for the fast diagnosis and treatment of stroke victims, has closed a £7m ($9.8m) funding roundt to bring its software to the global healthcare market.

Parkwalk lead […]

7 February 2018

Parkwalk wins at EISA Awards

By |February 7th, 2018|

Parkwalk are delighted to have won the ‘Best EIS Fund Manager’ category at the EISA awards on the 6th February 2018 at the House of Lords.

The award recognised an extremely strong 2017 for Parkwalk, where we committed in excess of £75m to hard-science, knowledge-intensive growth companies commercialising the best of British innovation spun-out of […]

Bodle Technologies – Parkwalk closes follow-on investment

By |February 5th, 2018|

We are delighted to announce that the Parkwalk Opportunities fund has led an investment in a £6m Series A funding round in to Bodle Technologies Limited, with participation from new investor Woodford Patient Capital Trust, as well as returning backers Oxford Sciences Innovation and the Oxford Technology and Innovations Fund.

The company intends to use the funds to […]

YASA – opens new 100,000 unit Oxford production facility

By |February 1st, 2018|

YASA’s  new Oxford production facility was officially opened today by the Secretary of State for Business, Energy and Industrial Strategy, the Rt Hon Greg Clark MP.  The opening follows the signing of long-term development and supply agreements with customers in the automotive sector and a further investment of £15 million in growth funding for […]

16 January 2018

Dynamic Vision Systems – Parkwalk closes investment

By |January 16th, 2018|

We are pleased to announce that we have closed an investment into the University of Manchester spinout Dynamic Vision Systems (DVS) for the Parkwalk Opportunities Fund. The company is built on collaborative efforts at the University of Manchester and the University of Leeds in the field of smart contact lenses.

The DVS technology arose from […]

GeoSpock – Parkwalk closes investment

By |January 10th, 2018|

We are pleased to announce that Parkwalk has participated in a follow-on funding round in GeoSpock.

GeoSpock, a spin-out from the University of Cambridge, provides a real-time scaleable database for rapidly changing complex data.

GeoSpock has recently begun marketing an extreme-scale, geo-location database product that provides real-time capture, storage, access and analysis for the rapidly increasing amount of […]

13 December 2017

Microsaic Systems – signs new phase of research agreement with a global partner in biopharma

By |December 13th, 2017|

Microsaic Systems plc
(“Microsaic” or the “Company”)
Microsaic signs new phase of research agreement with a global partner in biopharma
Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, announces that it has signed a research agreement extending its collaboration with a long standing global partner in the scale up and manufacture of biopharmaceutical […]

Xeros: Proposed £25m Placing

By |December 12th, 2017|

Xeros Technology Group plc
Proposed Placing to raise approximately £25 million
Xeros Technology Group plc (AIM: XSG, ‘the Group’, ‘Xeros’), the developer and provider of patented polymer based technologies with multiple commercial applications, intends to raise approximately £25 million before fees and expenses by a Placing of 11,111,112 new ordinary shares with existing and new institutional investors […]

Parkwalk closes Mirriad investment

By |December 8th, 2017|

We are pleased to announce that Parkwalk has participated in the successful Mirriad IPO. The company raised £26.2m on its admission to AIM.
Mirriad is the leading provider of NIVA (Native In-Video Advertising) services to brands and agencies looking to address the growing challenges presented by ‘ad skipping’ and ‘ad blindness’. The Mirriad technology was originally […]

21 November 2017

Perpetuum – Parkwalk closes follow on investment

By |November 21st, 2017|

We have recently closed a follow-on investment in Perpetuum for the Opportunities EIS Fund, alongside existing investors IP Group and ETF.

Perpetuum is a world-leader in vibration harvester-powered wireless sensing systems used to provide information to improve the efficiency, safety and quality of railway operations.

Perpetuum’s technology provides self-powered wireless conditioning monitoring solutions for rail applications and perpetual power for […]

Parkwalk – First Light Fusion Successful Exit

By |November 20th, 2017|

Parkwalk, the leading EIS investor in UK University spin-out companies, is pleased to announce the exit of the majority of its holding in First Light Fusion via a successful sale to Oxford Sciences Innovation.

Parkwalk was one of the initial investors in the company when it was formed in June 2011 and has invested in […]

Spectral Edge – Parkwalk closes investment

By |November 18th, 2017|

We are delighted to announce that the Parkwalk Opportunities EIS Fund has closed an investment in Spectral Edge, a spin-out from the University of East Anglia’s Colour Group.  Spectral Edge’s technology enhances images and video by using information outside the normal visible spectrum or applying transformations to that within it.

The company’s technology enhances images […]

Parkwalk closes Quantum Motion Technologies investment

By |November 15th, 2017|

We are delighted to announce that the Parkwalk Opportunities Fund has made an investment in Quantum Motion Technologies, a spin-out company from scientists at University of Oxford and UCL, as part of a Seed investment round of equity funding. The company aims to develop quantum computer architectures based on silicon technology, leveraging CMOS processing […]

Animal Dynamics – Parkwalk closes follow-on investment

By |November 12th, 2017|

We are pleased to have participated in a follow-on financing round in Animal Dynamics Limited, who are developing a portfolio of products derived from research into evolutionary adaptations in flight, swimming, walking, and stealth, where nature has arrived at significant performance optimisations which can be applied to commercial products.

Parkwalk closes Arvia investment

By |November 3rd, 2017|

We are delighted to announce that Parkwalk has made a follow-on investment into Arvia Technology from the Opportunities EIS Fund.

Arvia is exploiting a disruptive new technology for the treatment of organic and microbial wastes in water.  Spun-out from the University of Manchester, Arvia has received a plethora of major sustainability and technology innovation awards over the last five […]

Parkwalk and UOIF III close MoA investment

By |November 2nd, 2017|

We are pleased to announce that the University of Oxford Innovation Fund III, managed by Parkwalk, and the Parkwalk Opportunities EIS Fund have made an investment in MoA Technology, a spin-out from the University of Oxford. The company is developing novel technology with applications in plant protection products.

16 October 2017

Paragraf – Parkwalk and UCEF V investment

By |October 16th, 2017|

We are delighted to announce that the University of Cambridge Enterprise Fund V and the Parkwalk Opportunities Fund have invested in £2.64m seed financing round in Paragraf, a spin-out from the University of Cambridge.

Paragraf is aiming to deliver the speculated capabilities of graphene and other two-dimensional materials to the real world.

Building on fundamental science […]

MedaPhor – Parkwalk investment

By |October 13th, 2017|

We are delighted to announce that the Parkwalk Opportunities Fund has  participated in the recent financing round of Medaphor Group plc, the Cardiff University Spin-out and global provider of advanced ultrasound training simulators for medical professionals.